Why should you avoid DaVita stock?
DaVita's high financial leverage creates significant fixed obligations that could weigh on the stock, especially if profitability declines. If technology is introduced that makes dialysis unnecessary in the long run and DaVita hasn't bet on the correct technology, demand for its services may eventually decline.
What is the stock symbol for DaVita?
Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA.". Davita declared that its board has approved a stock buyback program on Wednesday, October 11th 2017, which authorizes the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor.
How much of DaVita's stock is owned by insiders?
In the past three months, DaVita insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $125,424.00 in company stock. Only 1.00% of the stock of DaVita is held by insiders. 84.28% of the stock of DaVita is held by institutions.
Is Davita a “underperform” stock?
DaVita has received 470 “outperform” votes. (Add your “outperform” vote.) DaVita has received 275 “underperform” votes. (Add your “underperform” vote.) DaVita has received 63.09% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about DaVita and other stocks.
See more
Should I sell DaVita stock?
It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors.
Is DaVita undervalued?
In the first nine months of 2021, the company earned $843 million in FCF, compared to $977 million in the same period in 2020. With an enterprise value of $22.17 billion, DaVita has an FCF yield of 5.5%, which is a very attractive rate and shows that the market has undervalued the company's growing FCF.
Is DaVita on the stock market?
Stock Quote (U.S.: NYSE) | MarketWatch....$ 96.23.CloseChgChg %$96.70-0.15-0.15%
When did DaVita stock split?
The first split for DVA took place on June 16, 2004. This was a 3 for 2 split, meaning for each 2 shares of DVA owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split. DVA's second split took place on September 09, 2013.
Does DaVita stock pay dividends?
DAVITA (NYSE: DVA) does not pay a dividend.
How big is DaVita?
As of March 31, 2019, DaVita serves 203,500 patients at 2,689 outpatient dialysis centers in the United States. The company also operates 234 outpatient dialysis centers in nine countries across the world.
What does Warren Buffett Own?
Through his holding company Berkshire Hathaway, Warren Buffett owns Stakes in Apple, Bank of America, American Express, Goldman Sachs, Wells Fargo, Coca-Cola, Visa, and Mastercard. With over $211 Billion invested in over 60 companies, the Buffett/Berkshire portfolio is one of the largest and most profitable globally.
Should I buy or sell DaVita stock right now?
6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DaVita in the last year. There are currently 5 hold rati...
What is DaVita's stock price forecast for 2022?
6 brokers have issued 1-year price objectives for DaVita's stock. Their forecasts range from $110.00 to $150.00. On average, they predict DaVita's...
How has DaVita's stock price performed in 2022?
DaVita's stock was trading at $113.76 at the start of the year. Since then, DVA shares have decreased by 18.1% and is now trading at $93.16. View...
When is DaVita's next earnings date?
DaVita is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022. View our earnings forecast for DaVita .
How were DaVita's earnings last quarter?
DaVita Inc. (NYSE:DVA) announced its earnings results on Thursday, May, 5th. The company reported $1.61 earnings per share for the quarter, missing...
What guidance has DaVita issued on next quarter's earnings?
DaVita updated its FY 2022 earnings guidance on Monday, May, 23rd. The company provided EPS guidance of $7.50-$8.50 for the period, compared to the...
Who are DaVita's key executives?
DaVita's management team includes the following people: Mr. Javier J. Rodriguez , CEO & Exec. Director (Age 51, Pay $3.3M) ( LinkedIn Profile )...
What is Javier Rodriguez's approval rating as DaVita's CEO?
289 employees have rated DaVita CEO Javier Rodriguez on Glassdoor.com . Javier Rodriguez has an approval rating of 77% among DaVita's employees.
Who are some of DaVita's key competitors?
Some companies that are related to DaVita include Laboratory Co. of America (LH) , Quest Diagnostics (DGX) , Chemed (CHE) , R1 RCM (RCM) , LHC...
What is a Davita?
Is Davita a hold?
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
How long are futures trading delayed?
Wall Street analysts have given DaVita a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DaVita wasn't one of them.
How to calculate restricted stock?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
New York Stock Exchange
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
Environmental, Social, and Governance Rating
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney Patients
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
DaVita Kidney Care Appoints New Chief Medical Officer of Home Modalities
Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis patients who received an mRNA-based vaccine (Pfizer/BioNTech), according to a DaVita Clinical Research (DCR) study published online ahead of print by the Journal of the American Society of Nephrology..
DaVita expands paid leave to support teammates choosing to be living organ donors
DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities.
DaVita's (DVA) Q4 Earnings Surpass Estimates, Margins Up
In honor of National Donor Day—and every living organ donor—DaVita announced it increased paid leave for organ donation to four consecutive weeks for benefits-eligible teammates (employees) who donate their bone marrow, liver or kidney.
Denver-based DaVita shifts to treating Covid-19 impact as 'new normal'
DaVita's (DVA) strength in dialysis patient service revenues drives its Q4 top line.
DaVita (DVA) Q4 2021 Earnings Call Transcript
DaVita Inc.
DaVita HealthCare (DVA) Surpasses Q4 Earnings and Revenue Estimates
At this time, I would like to welcome everyone to the DaVita fourth quarter 2021 earnings call. Thank you, Jim, and thank you all for joining today's call to discuss our fourth-quarter performance and our thoughts on 2022.
